These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31203725)

  • 1. Effects of Nilvadipine on Cerebral Blood Flow in Patients With Alzheimer Disease.
    de Jong DLK; de Heus RAA; Rijpma A; Donders R; Olde Rikkert MGM; Günther M; Lawlor BA; van Osch MJP; Claassen JAHR
    Hypertension; 2019 Aug; 74(2):413-420. PubMed ID: 31203725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure Lowering With Nilvadipine in Patients With Mild-to-Moderate Alzheimer Disease Does Not Increase the Prevalence of Orthostatic Hypotension.
    de Heus RAA; Donders R; Santoso AMM; Olde Rikkert MGM; Lawlor BA; Claassen JAHR;
    J Am Heart Assoc; 2019 May; 8(10):e011938. PubMed ID: 31088188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
    Lawlor B; Segurado R; Kennelly S; Olde Rikkert MGM; Howard R; Pasquier F; Börjesson-Hanson A; Tsolaki M; Lucca U; Molloy DW; Coen R; Riepe MW; Kálmán J; Kenny RA; Cregg F; O'Dwyer S; Walsh C; Adams J; Banzi R; Breuilh L; Daly L; Hendrix S; Aisen P; Gaynor S; Sheikhi A; Taekema DG; Verhey FR; Nemni R; Nobili F; Franceschi M; Frisoni G; Zanetti O; Konsta A; Anastasios O; Nenopoulou S; Tsolaki-Tagaraki F; Pakaski M; Dereeper O; de la Sayette V; Sénéchal O; Lavenu I; Devendeville A; Calais G; Crawford F; Mullan M;
    PLoS Med; 2018 Sep; 15(9):e1002660. PubMed ID: 30248105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood Pressure Variability and Progression of Clinical Alzheimer Disease.
    de Heus RAA; Olde Rikkert MGM; Tully PJ; Lawlor BA; Claassen JAHR;
    Hypertension; 2019 Nov; 74(5):1172-1180. PubMed ID: 31542965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nilvadipine antagonizes both Abeta vasoactivity in isolated arteries, and the reduced cerebral blood flow in APPsw transgenic mice.
    Paris D; Quadros A; Humphrey J; Patel N; Crescentini R; Crawford F; Mullan M
    Brain Res; 2004 Feb; 999(1):53-61. PubMed ID: 14746921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R; Miyasaka Y; Maruyama S; Nagai S; Fujii K
    Neurol Res; 1996 Aug; 18(4):325-8. PubMed ID: 8875450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease.
    Matsuda H; Araki N; Kuji I; Ohkubo T; Imabayashi E; Shimazu K
    Clin Nucl Med; 2008 Jan; 33(1):34-5. PubMed ID: 18097255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.
    Meulenbroek O; O'Dwyer S; de Jong D; van Spijker G; Kennelly S; Cregg F; Olde Rikkert M; Abdullah L; Wallin A; Walsh C; Coen R; Kenny RA; Daly L; Segurado R; Borjesson-Hanson A; Crawford F; Mullan M; Lucca U; Banzi R; Pasquier F; Breuilh L; Riepe M; Kalman J; Molloy W; Tsolaki M; Howard R; Adams J; Gaynor S; Lawlor B
    BMJ Open; 2016 Jul; 6(7):e011584. PubMed ID: 27436668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nilvadipine increases cerebral blood flow in elderly hypertensives: comparison with nifedipine.
    Shimamoto H; Shimamoto Y
    J Hum Hypertens; 1995 Apr; 9(4):271-9. PubMed ID: 7595910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G;
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NILVAD protocol: a European multicentre double-blind placebo-controlled trial of nilvadipine in mild-to-moderate Alzheimer's disease.
    Lawlor B; Kennelly S; O'Dwyer S; Cregg F; Walsh C; Coen R; Kenny RA; Howard R; Murphy C; Adams J; Daly L; Segurado R; Gaynor S; Crawford F; Mullan M; Lucca U; Banzi R; Pasquier F; Breuilh L; Riepe M; Kalman J; Wallin A; Borjesson A; Molloy W; Tsolaki M; Olde Rikkert M
    BMJ Open; 2014 Oct; 4(10):e006364. PubMed ID: 25300460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of the angiotensin II receptor antagonist olmesartan in controlling hypertension and cerebral hemodynamics after stroke.
    Matsumoto S; Shimodozono M; Miyata R; Kawahira K
    Hypertens Res; 2009 Nov; 32(11):1015-21. PubMed ID: 19745828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial.
    Dolui S; Detre JA; Gaussoin SA; Herrick JS; Wang DJJ; Tamura MK; Cho ME; Haley WE; Launer LJ; Punzi HA; Rastogi A; Still CH; Weiner DE; Wright JT; Williamson JD; Wright CB; Bryan RN; Bress AP; Pajewski NM; Nasrallah IM
    JAMA Neurol; 2022 Apr; 79(4):380-389. PubMed ID: 35254390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial.
    Butcher KS; Jeerakathil T; Hill M; Demchuk AM; Dowlatshahi D; Coutts SB; Gould B; McCourt R; Asdaghi N; Findlay JM; Emery D; Shuaib A;
    Stroke; 2013 Mar; 44(3):620-6. PubMed ID: 23391776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nilvadipine in hypertension--experience in ambulatory treatment.
    Hoffmann A; Kraul H; Burkardt I
    Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hemorheological effects of the calcium antagonist nilvadipine in essential hypertension.
    Tsuda Y; Satoh K; Kitadai M; Izumi Y; Takahashi T
    Arzneimittelforschung; 1997 Aug; 47(8):900-4. PubMed ID: 9296274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood Pressure Is Not Associated With Cerebral Blood Flow in Older Persons.
    Foster-Dingley JC; Moonen JE; de Craen AJ; de Ruijter W; van der Mast RC; van der Grond J
    Hypertension; 2015 Nov; 66(5):954-60. PubMed ID: 26351027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of single oral administration of nilvadipine on cerebral blood flow in chronic cerebral infarction.
    Kobayashi S; Yamaguchi S; Okada K; Suyama N; Bokura K; Murao M; Tsunematsu T
    Angiology; 1992 Oct; 43(10):801-9. PubMed ID: 1476267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.